298. Successful Treatment of Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection in an Immunocompromised Patient

BACKGROUND: The COVID-19 pandemic has been marked by long-term persistence of SARS-CoV-2 in immunocompromised patients receiving B-cell-depleting therapies, with many individuals experiencing fatal COVID-19. METHODS: We report an individual treated with rituximab who survived persistent COVID-19 ove...

Descripción completa

Detalles Bibliográficos
Autores principales: Overbeck, Victoria, Turcinovic, Jacquelyn, Qiu, Xueting, Seitz, Scott, Connor, John, Schaeffer, Beau, Hanage, William P, Curry, Scott R, Kuppalli, Krutika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751565/
http://dx.doi.org/10.1093/ofid/ofac492.376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751565/
http://dx.doi.org/10.1093/ofid/ofac492.376

Ejemplares similares